Clinical Trial Update: Study of Triostat in Infants During Heart Surgery [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for Triostat (liothyronine) used in infants undergoing heart surgery, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects

Drugs mentioned

• Triostat (liothyronine)

Snippet

Sponsor: Michael Portman | Conditions: Heart Defects, Congenital | Phase 3 | Status: COMPLETED